Here are some of Pauli’s thoughts on Atria before the Q3 review. 
Atria will report its Q3 interim report on Wednesday, 23 October. We see the operating environment gradually becoming more favorable for Atria as cost pressures in primary production ease and consumer demand potentially picks up with falling interest rates. We slightly raised our forecasts for 2024-25 and expect Atria to report a reasonably good result for Q3 as well.
You could tell from X as well that Atria surprised, and here are Pauli’s quick comments on the results.
Atria reported its Q3 interim report today. We see the overall picture of the report as positive, as the adjusted operating profit exceeded our forecasts by as much as 31%. Both the Finnish and Swedish units managed to clearly improve their operating results, influenced by, among other things, a successful summer sales season, efficiency measures, and the completion of significant production projects. We estimate that the strong result will have a positive impact (approx. 5%) on the consensus operating profit forecasts for 2025.
Here is a fresh report on Atria by Pauli.
The strong Q3 report sent a message about a significant improvement in Atria’s internal efficiency following the investments and streamlining measures of recent years. However, there is still increased uncertainty regarding the sustainability of the high earnings level. Nevertheless, we see the valuation as exceptionally attractive for Atria and the entire industry, offering a sufficient margin of safety for a Buy recommendation (prev. Accumulate). We raise the target price to EUR 13 (prev. 11.5).
Quoted from the report:
We consider the adjusted EV/EBIT ratio to be the best valuation metric for Atria, as it best takes into account the balance sheet structure and, through depreciation, also the long-term investment needs. We have also moderately factored the value of Atria’s associates into the EV/EBIT ratio using a P/B multiple of 0.7x. With our increased forecasts, the adjusted EV/EBIT for 2024-25 is 8x for Atria. This is significantly lower than the company’s 5-year historical average (~12x) and the peer group (12x). The peer group consists of domestic food industry companies and meat industry players from across Europe and North America.
@henrielo has written an analysis of Atria.
In Sweden and especially in Estonia, food basket inflation has continued, which can be seen from the table: value development in Estonia has been 4.6 percentage points faster than volume development. In Sweden, the prices of sausages and cold cuts have risen significantly over the past 12 months.
note
IR-ikkuna is a channel for the corporate partners of SalkunRakentaja and Sijoittaja.fi for background and analytical articles as well as other interesting investor information. The article is part of a commercial collaboration with the company. The article does not contain investment recommendations.
The author owns shares in the company.
It will be interesting to see whether the new nutritional recommendations will resonate within Atria’s product portfolio or in the purchasing decisions of the general public. The consumption of cold cuts is considered to involve such an increased risk of intestinal tumors that it prompted the new recommendation.
Interesting to see if the new nutritional recommendations will have any resonance in Atria’s product range or in the general public’s purchasing decisions
Just as much as the previous ones have had 
Pauli has written a comprehensive and interesting article about the food industry, which will surely interest the readers of this thread. Atria is naturally mentioned separately in the article as well.
Tässä on Nordean tiivis katsaus Atriaan englanniksi. 
Peer and competitor in Finland, HKFoods is out with a positive profit warning stating its 2024 comparable EBIT was EUR 27-28m (was previously expecting EUR 22-25m, i.e. mid-point up 17%). HKFoods states that operative and commercial performance has improved while Christmas sales were particularly strong. New guidance implies around EUR 10m comparable EBIT in Q4 (LSEG consensus at EUR 6.3m after EUR 3m in Q4 2023). For Atria, we have modelled EUR 16.4m adjusted EBIT in Q4E (consensus EUR 16.3m, up from EUR 9.3m in Q4 2023, which was burdened by new poultry unit ramp-up). We view HKFoods positive profit warning as positive when considering Atria Q4 performance, especially owing to reasoning around Christmas sales. Atria will report its Q4 on 13 February.
Below are Nordea’s thoughts before the Q4 results. Nordea believes the new poultry unit will support profitability, and they also expect lower grain prices to improve the result.
This bank expects positive guidance for 2025.
Here are Pauli’s preliminary comments regarding the Q4 results to be published on Thursday.
We expect the company to be able to improve its earnings in Q4 compared to the weak comparison period. Even more interesting is what the company guides for 2025. Our and consensus forecasts assume stable earnings development, but we also see drivers for continued earnings growth. If the company were to guide for rising earnings, the share price would likely react positively, considering the low earnings-based valuation multiples.
No one is really interested in Atria, but it’s a good dividend payer; I don’t own it myself. The financial statement release is quite informative and comprehensive: Atria Oyj:n tilinpäätöstiedote 1.1.-31.12.2024 | Kauppalehti
October-December 2024
January-December 2024
Future Outlook and Earnings Guidance
Atria Group’s adjusted operating profit in 2025 is estimated to be lower than in the previous year (EUR 65.4 million).
After a record-breaking earnings year, supported by significant efficiency and expansion investments carried out in 2023-24, Atria is well-positioned to perform well in 2025. Atria’s strong market position, robust brands, good customer relationships, and reliably operating industrial processes create the conditions for business stability.
However, the continuing unstable global trade and geopolitical situation and its impact on consumer confidence and market growth weaken the outlook for 2025. Similarly, updated nutritional recommendations may reduce the sales of meat products. Furthermore, labor market negotiations in Finland and the animal disease situation in Europe may have a negative impact on the company’s results in 2025.
Board’s Proposal for Dividend 2024
The Board proposes that the company distribute a dividend of EUR 0.69 per share for 2024 (In 2023: EUR 0.30 dividend/share + EUR 0.30 capital repayment/share).
If one wants to find something positive from that report, the cash flow in Q4 was €31.4 million vs. investment cash flow of €12.9 million, which results in a Q4 free cash flow of €18.5 million. 
I have mixed feelings about it. It was known that we would start this year from challenging and uncertain positions, but the guidance for a declining result was still a disappointment.
We’ll see how the market reacts. If only this new, improved earnings level would be more fully reflected in the share price.
Paulikin has already written quick comments on Atria’s Q4 results.
Atria reported its Q4 financial statement this morning. The earnings lines fell slightly short of our and the consensus expectations. The guidance was also set cautiously, which may have a small negative impact on consensus earnings forecasts for the current year. Overall, the report was thus a slight disappointment compared to expectations. However, one should not necessarily draw too sharp conclusions from the guidance, as Atria has been a rather cautious guide in recent years.
An article in the local newspaper, paywall is a nuisance.
But a small quote:
"As a new risk factor, Atria sees the national nutrition recommendations published in the autumn and their impact on consumers’ eating habits. According to the recommendations, the consumption of vegetables, berries, fruits, and legumes, among other things, should be increased, and the consumption of red meat should be reduced.
According to Gyllström, the matter has already affected the demand for Atria’s products.
– It is particularly visible in cold cuts right now"
Here is a fresh company report from Paul on Atria after Q4.
Earnings development continued to be positive year-on-year in Q4, but still fell short of expectations. Atria’s declining earnings guidance for 2025 was more cautious than our expectations, which the company justified with uncertainties related to the operating environment. If the operating environment remains stable, we estimate the company could exceed its guidance, and therefore we still forecast stable operating profit.
That should certainly be taken into account in the product offering. A few years ago, Atria launched an extensive Vegyu product line, which was actively advertised, for example, on television. One product was worse than the other, and quite soon the products were removed from the market. A good amount of money was probably spent, but they should have invested in the products as well.
It is clear that in the future, Atria must be able to profile itself better specifically as a food company, and not just a meat company. This requires not only greater expansion beyond meat products but also investing in the quality of semi-finished and ready-made meals. Currently, for example, with portion meals, the price often comes first, while smaller players are increasingly taking up shelf space in stores with higher quality products.
@henrielo has written an analysis about Atria.
Subheadings:
Note.
The author owns shares in the company.
IR Window is a channel for SalkunRakentaja’s and Sijoittaja.fi’s corporate partners, providing background and analytical articles, as well as other interesting investor information. The article is part of a commercial collaboration with the company. The article does not contain investment recommendations.
Here are Paul’s comments on Atria’s recent investment program.
Atria plans to modernize its convenience food production, which includes both strengthening energy efficiency and expanding production. Convenience foods as a segment are growing rapidly and play a key role in Atria’s strategy. The investment program is significant in size, but we do not see it causing immediate significant pressure for change in our forecasts.
A certain “group” is clearly not satisfied with Atria’s products.
The local newspaper article has a paywall.